These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33276026)

  • 1. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
    Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
    J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum and precision oncology for biliary tract carcinoma.
    Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
    Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
    [No Abstract]   [Full Text] [Related]  

  • 3. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
    Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
    Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
    Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive single-cell analysis deciphered microenvironmental dynamics and immune regulator olfactomedin 4 in pathogenesis of gallbladder cancer.
    He H; Chen S; Yu Y; Fan Z; Qian Y; Dong Y; Song Y; Zhong C; Sun X; Cao Q; Li S; Huang W; Li W; Zhuang M; Yang J; Wang X; Wang J; Wu D; Wang H; Wen W
    Gut; 2024 Aug; 73(9):1529-1542. PubMed ID: 38719336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Aflatoxin and Gallbladder Cancer.
    Koshiol J; Gao YT; Dean M; Egner P; Nepal C; Jones K; Wang B; Rashid A; Luo W; Van Dyke AL; Ferreccio C; Malasky M; Shen MC; Zhu B; Andersen JB; Hildesheim A; Hsing AW; Groopman J
    Gastroenterology; 2017 Aug; 153(2):488-494.e1. PubMed ID: 28428144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.
    Fan B; Xu X; Wang X
    Mol Biol Rep; 2022 Feb; 49(2):1295-1301. PubMed ID: 34988893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
    Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
    PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
    García P; Bizama C; Rosa L; Espinoza JA; Weber H; Cerda-Infante J; Sánchez M; Montecinos VP; Lorenzo-Bermejo J; Boekstegers F; Dávila-López M; Alfaro F; Leiva-Acevedo C; Parra Z; Romero D; Kato S; Leal P; Lagos M; Roa JC
    Biol Res; 2020 Apr; 53(1):13. PubMed ID: 32293552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma.
    Seo JS; Lee JW; Kim A; Shin JY; Jung YJ; Lee SB; Kim YH; Park S; Lee HJ; Park IK; Kang CH; Yun JY; Kim J; Kim YT
    Cancer Immunol Res; 2018 Jul; 6(7):848-859. PubMed ID: 29720381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
    Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
    BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
    Kawakami S; Takano S; Fukasawa M; Shindo H; Takahashi E; Fukasawa Y; Hayakawa H; Kuratomi N; Kadokura M; Hosomura N; Amemiya H; Kawaida H; Kono H; Maekawa S; Ichikawa D; Enomoto N
    BMC Cancer; 2021 Nov; 21(1):1245. PubMed ID: 34798839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic
    Li M; Liu F; Zhang F; Zhou W; Jiang X; Yang Y; Qu K; Wang Y; Ma Q; Wang T; Bai L; Wang Z; Song X; Zhu Y; Yuan R; Gao Y; Liu Y; Jin Y; Li H; Xiang S; Ye Y; Zhang Y; Jiang L; Hu Y; Hao Y; Lu W; Chen S; Gu J; Zhou J; Gong W; Zhang Y; Wang X; Liu X; Liu C; Liu H; Liu Y; Liu Y
    Gut; 2019 Jun; 68(6):1024-1033. PubMed ID: 29954840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
    Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
    World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
    Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
    Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
    Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
    Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid.
    Domingo-Sabugo C; Willis-Owen SA; Mandal A; Nastase A; Dwyer S; Brambilla C; Gálvez JH; Zhuang Q; Popat S; Eveleigh R; Munter M; Lim E; Nicholson AG; Lathrop GM; Cookson WO; Moffatt MF
    J Pathol; 2024 Nov; 264(3):332-343. PubMed ID: 39329437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation.
    Yang S; Qin L; Wu P; Liu Y; Zhang Y; Mao B; Yan Y; Yan S; Tan F; Yue X; Liu H; Xue H
    PLoS One; 2023; 18(3):e0283770. PubMed ID: 36996251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.